EP2421517A4 - Dispositif d'administration à libération contrôlée - Google Patents

Dispositif d'administration à libération contrôlée

Info

Publication number
EP2421517A4
EP2421517A4 EP10767428.5A EP10767428A EP2421517A4 EP 2421517 A4 EP2421517 A4 EP 2421517A4 EP 10767428 A EP10767428 A EP 10767428A EP 2421517 A4 EP2421517 A4 EP 2421517A4
Authority
EP
European Patent Office
Prior art keywords
controlled release
dispensing device
release dispensing
controlled
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP10767428.5A
Other languages
German (de)
English (en)
Other versions
EP2421517A2 (fr
Inventor
Libin Barry
Jeffrey M Liebmann
Weiliam Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SUSTAINED NANO SYSTEMS LLC
Original Assignee
SUSTAINED NANO SYSTEMS LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/386,853 external-priority patent/US8071119B2/en
Priority claimed from US12/592,536 external-priority patent/US20100173000A1/en
Application filed by SUSTAINED NANO SYSTEMS LLC filed Critical SUSTAINED NANO SYSTEMS LLC
Publication of EP2421517A2 publication Critical patent/EP2421517A2/fr
Publication of EP2421517A4 publication Critical patent/EP2421517A4/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP10767428.5A 2009-04-23 2010-04-21 Dispositif d'administration à libération contrôlée Ceased EP2421517A4 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US21445209P 2009-04-23 2009-04-23
US12/386,853 US8071119B2 (en) 2007-05-14 2009-04-23 Controlled release implantable dispensing device and method
US12/592,536 US20100173000A1 (en) 2007-05-14 2009-11-25 Controlled release implantable dispensing device and method
PCT/US2010/001191 WO2010123563A2 (fr) 2009-04-23 2010-04-21 Dispositif d'administration à libération contrôlée

Publications (2)

Publication Number Publication Date
EP2421517A2 EP2421517A2 (fr) 2012-02-29
EP2421517A4 true EP2421517A4 (fr) 2013-08-07

Family

ID=43011665

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10767428.5A Ceased EP2421517A4 (fr) 2009-04-23 2010-04-21 Dispositif d'administration à libération contrôlée

Country Status (4)

Country Link
EP (1) EP2421517A4 (fr)
JP (2) JP2012524779A (fr)
CA (1) CA2759807C (fr)
WO (1) WO2010123563A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013020094A2 (fr) * 2011-08-03 2013-02-07 Avant Garde Therapeutics Inc. Nouveau timbre hémostatique et leurs utilisations
WO2019014269A1 (fr) * 2017-07-11 2019-01-17 Sustained Nano Systems Llc Stérilisation par rayonnement de formes posologiques de polymère hypercomprimées
CN110913907B (zh) 2017-07-11 2024-08-16 持续纳米系统有限责任公司 超压缩药物制剂
BR102020025389A2 (pt) * 2020-12-11 2022-06-21 Edson Luiz Peracchi Implante subcutâneo reabsorvível de longa duração com liberação prolongada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da dependência a nicotina e processo

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020111603A1 (en) * 1996-12-02 2002-08-15 Societe De Conseils De Recherches Et D'application Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5899411A (ja) * 1981-12-05 1983-06-13 Shoichiro Ozaki 制ガン剤
US4478818A (en) * 1982-12-27 1984-10-23 Alza Corporation Ocular preparation housing steroid in two different therapeutic forms
CH679207A5 (fr) * 1989-07-28 1992-01-15 Debiopharm Sa
FR2756493B1 (fr) * 1996-12-02 2001-04-13 Delab Dispositif d'administration locale de formulations solides ou semi-solides
WO1999048519A1 (fr) * 1998-03-20 1999-09-30 Takeda Chemical Industries, Ltd. Preparation de polypeptide physiologiquement actif, a liberation prolongee, et production correspondante
DE19856432A1 (de) * 1998-12-08 2000-06-15 Basf Ag Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen
DE10224170A1 (de) * 2002-05-31 2003-12-11 Desitin Arzneimittel Gmbh Pharmazeutische Zusammensetzung mit verzögerter Wirkstofffreisetzung
JP4475891B2 (ja) * 2003-06-20 2010-06-09 ホソカワミクロン株式会社 経肺製剤の製造方法
MX2007001760A (es) * 2004-08-12 2007-07-24 Quest Pharmaceutical Services Composiciones farmaceuticas para la distribucion de liberacion controlada de compuestos biologicamente activos.
FR2880273B1 (fr) * 2004-12-30 2007-03-30 Ceva Sante Animale Sa Procede de separation d'une composition pharmaceutique solide a liberation prolongee et controlee sous hautes pressions
US20080292680A1 (en) * 2007-05-14 2008-11-27 Sustained Nano Systems Llc Hypercompressed polymer particles for controlled release ophthalmic medications

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020111603A1 (en) * 1996-12-02 2002-08-15 Societe De Conseils De Recherches Et D'application Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process

Also Published As

Publication number Publication date
CA2759807A1 (fr) 2010-10-28
JP2012524779A (ja) 2012-10-18
CA2759807C (fr) 2018-03-20
WO2010123563A3 (fr) 2011-03-17
WO2010123563A2 (fr) 2010-10-28
EP2421517A2 (fr) 2012-02-29
JP6250005B2 (ja) 2017-12-20
JP2016028066A (ja) 2016-02-25

Similar Documents

Publication Publication Date Title
HK1203163A1 (en) Medicament dispensing device
EP2427379A4 (fr) Appareil de distribution
EP2412594A4 (fr) Dispositif de commande de freinage
EP2413443A4 (fr) Dispositif de génération d'ions
GB0909818D0 (en) Device
GB0905352D0 (en) Device
GB201014809D0 (en) Improved dispensing device
EP2441976A4 (fr) Dispositif anti-vibration
EP2409882A4 (fr) Dispositif de ceinture de sécurité
EP2295987A4 (fr) Dispositif de distribution
ZA201105956B (en) Ejection device
EP2521148A4 (fr) Dispositif de stockage d'électricité
ZA201105243B (en) Dispensing device
EP2421517A4 (fr) Dispositif d'administration à libération contrôlée
EP2476591A4 (fr) Dispositif pour ceinture de sécurité
GB0908083D0 (en) Anti-pecking device
GB2474673B (en) Dispensing device
GB2474424B (en) Controlled dispenser
GB2473070B (en) Dispensing apparatus
GB0909368D0 (en) Device
GB0900160D0 (en) Device
IL214193A0 (en) Doseg dispensing device
GB2469664B (en) Dispensing apparatus
IL216966A0 (en) Local therapeutic release device
GB0820080D0 (en) Dispensing device

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20111028

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20130708

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/20 20060101ALI20130702BHEP

Ipc: A61K 9/52 20060101AFI20130702BHEP

Ipc: A61K 9/51 20060101ALI20130702BHEP

Ipc: A61K 9/00 20060101ALI20130702BHEP

Ipc: A61K 9/50 20060101ALI20130702BHEP

Ipc: A61M 35/00 20060101ALI20130702BHEP

Ipc: A61K 9/16 20060101ALI20130702BHEP

Ipc: A61K 47/30 20060101ALI20130702BHEP

17Q First examination report despatched

Effective date: 20140325

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20190308